Goldman Sachs Group »

Cytomx Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $133k 109k 1.22
2024-03-31 $641k 294k 2.18
2023-06-30 $18k 10k 1.72
2023-03-31 $20k 13k 1.51
2022-12-31 $166k 104k 1.60
2022-06-30 $343k 188k 1.83
2022-03-31 $2.0M 759k 2.67
2021-12-31 $2.8M 637k 4.33
2021-09-30 $5.6M 1.1M 5.09
2021-03-31 $1.6M 209k 7.73
2020-12-31 $1.5M 227k 6.55
2020-09-30 $1.9M 280k 6.65
2020-06-30 $2.3M 278k 8.33
2019-12-31 $3.3M 401k 8.31
2019-09-30 $2.9M 389k 7.38
2019-06-30 $4.6M 406k 11.22
2019-03-31 $2.1M 197k 10.75
2018-12-31 $7.5M 498k 15.10
2018-09-30 $8.4M 456k 18.50
2018-06-30 $12M 521k 22.86
2018-03-31 $12M 419k 28.44
2017-12-31 $9.7M 458k 21.11
2017-09-30 $5.9M 325k 18.18
2017-06-30 $2.0M 128k 15.49
2017-03-31 $190k 11k 17.30
2015-12-31 $319k 15k 20.88